ARCHIVES

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

This article is from The Cancer Letter archive.

Vol. 40 No. 27 | July 4, 2014

Download PDF Visit The Full Archive

Related Articles

Season’s Greetings from the Cancer Letter

December 17, 1999

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

Educational Strategies On Mammography, Not Guidelines, To Come From NCAB

February 28, 1997

In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State

July 30, 1993

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

November 27, 1987

Consensus Panel Say Surgery, Radiation Both Effective For Clinically Local Prostate Cancer

June 26, 1987